|Videos|June 19, 2016

What Pathogens Are Most Affected by the Colistin-Resistant mcr-1 Gene?

Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, explains which pathogens are most affected by the colistin resistant mcr-1 gene.

Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, explains which pathogens are most affected by the colistin resistant mcr-1 gene.

Interview Transcript (slightly modified for readability)

“The pathogens most affected by the spread of the mcr-1 gene, that is the gene that confers resistance to colistin, are, at the moment, Escherichia coli (E. coli), but there are also reports of other gram-negative bacteria that are important in human medicine like, Klebsiella pneumoniae.

We speculate, at the moment, that this gene is present in E. coli. E. coli is a pathogen that can be present in the intestinal tract of humans, [and] also animals and it can spread in the environment, and can also affect the food chain, [such as] the meat and the vegetables.

The mechanism of resistance is transferred to other pathogens via plasmids. Plasmids are DNA, small elements that are able to pass via conjugation. One pathogen that possesses this plasmid carrying the mcr-1 can conjugate with another one of the same species (ex: coli to coli), but also between different species (ex: coli to Klebsiella) and transfer this plasmid that carries the mcr-1, making the recipient that originally was not colistin-resistant, colistin resistant.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.